![General Commons Logo](./assets/images/crdc-logo.svg) 
# caNanoLab DOI 
-------------------------- 
## DOI:	[10.17917/HA0Q-5B49](http://dx.doi.org/10.17917/HA0Q-5B49) 
**Protocol Name:**	NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot  
**Protocol Abbreviation:**	ITA-5.1  
**Protocol Version:**	3  
-------------------------- 
### Resource Type:	Protocol 
### Publication Status:	publication_status 
#### Created Date:	2020-06-19 08:34:00 
-------------------------- 
| Property | Value | 
|----------|---------| 
| Sample ID | 92471313 | 
| Sample Name | Nanoemulsion + Gd + Ceramide + PTX (NCL59) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471312 | 
| Sample Name | Nanoemulsion + Gd + Ceramide (NCL58) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471311 | 
| Sample Name | Nanoemulsion + Gd + PTX (NCL57) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471310 | 
| Sample Name | Nanoemulsion + Gd (NCL56) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471309 | 
| Sample Name | Nanoemulsion (NCL55) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471297 | 
| Sample Name | Gum Arabic-Stabilized Gold Nanoparticle with Bisphosphonate (BP) initiation (NCL79) | 
| Organization | NCL, Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471296 | 
| Sample Name | Gum Arabic-Stabilized Gold Nanoparticle with THPAL initiation (NCL78) | 
| Organization | NCL, Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 91488258 | 
| Sample Name | Hollow Gold Nanospheres (NCL211) | 
| Organization | NCL, Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 91488257 | 
| Sample Name | Hollow Gold Nanospheres (NCL212) | 
| Organization | NCL, Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Characterization ID | 92602422|92602420|92602411|92602413|93519917|93519875|93519880|93519895|93519885|93519890|92602429|92602431|93519900|93519915|93519905|93519910 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|systemic toxicity assessment|caspase 3 activity in Hep G2 cells|caspase 3 activity in LLC-PK1 cells|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602424|92602419|92602410|92602416|93519874|93519879|93519894|93519884|93519889|92602428|92602434|93519899|93519914|93519904|93519909 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602425|92602421|92602412|92602417|93519876|93519881|93519896|93519886|93519891|92602430|92602435|93519901|93519916|93519906|93519911 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602423|92602418|92602409|92602415|93519873|93519878|93519893|93519883|93519888|92602426|92602433|93519898|93519913|93519903|93519908 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602408|92602414|93519872|93519877|93519892|93519882|93519887|92602427|92602432|93519897|93519912|93519902|93519907 | 
| Characterization Type | physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602372|92602377|92602379|92602384|92602394|92602390|92602392|92602386|92602388|92602368|92602370 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['UV-vis Spectroscopy|Dynamic Light Scattering|Transmission electron microscopy (TEM)|surface|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|bacterial/yeast/mold|endotoxin'] | 
| Characterization ID | 92602373|92602376|92602378|92602382|92602393|92602389|92602391|92602385|92602387|92602369|92602371 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['UV-vis Spectroscopy|Dynamic Light Scattering|Transmission electron microscopy (TEM)|surface|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|bacterial/yeast/mold|endotoxin'] | 
| Characterization ID | 91619350|91619349|91619345|91619348|91619365|91619360|91619363|91619355|91619358|91619333|91619335 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['ICP-MS|Dynamic Light Scattering|size|Zeta Potential|complement activation|hemolysis|platelet aggregation|MTT|MTT|bacterial/yeast/mold|endotoxin'] | 
| Characterization ID | 91619353|91619337|91619342|91619346|91619366|91619359|91619364|91619354|91619357|91619332|91619334 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['ICP-MS|Dynamic Light Scattering|size|Zeta Potential|complement activation|hemolysis|platelet aggregation|MTT|MTT|bacterial/yeast/mold|endotoxin'] | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | metallic | 
| Nanomaterial Entity Type | metallic | 
| Nanomaterial Entity Type | metallic | 
| Nanomaterial Entity Type | metallic | 
| Protocol ID | 88539147 | 
| Protocol Type | in vitro assay | 
| Protocol Name |NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot | 
| Composing Element Type | composing_element_type | 
| Composing Element Chemical Name | composing_element_chemical_name | 
| File Name | protocols/20240410_19-14-27-447_NCL_Method_ITA-5.1.pdf | 
| File URI | protocols/20240410_19-14-27-447_NCL_Method_ITA-5.1.pdf | 
| Nanomaterial Entity File Type | nanomaterial_entity_file_type | 
| Chemical Association File Type Title | chemical_association_file_type_title | 
